Plasmodium spp. is the etiological agent of malaria, a life-threatening parasitic disease
transmitted by infected mosquitoes. Malaria remains a major global health challenge …

The observation that inactivated Plasmodium sporozoites could protect against malaria is
about a hundred years old. However, systematic demonstration of protection using irradiated …

An effective malaria vaccine that reduces morbidity and mortality and contributes to malaria
elimination is a much-needed tool, particularly in endemic areas where health-care delivery …

Introduction: The challenge to eradicate malaria is an enormous task that will not be
achieved by current control measures, thus an efficacious and long-lasting malaria vaccine …

Abstract The Malaria Vaccine Symposium occurred at Johns Hopkins University in
Baltimore, MD, USA on April 25th, 2017, coinciding with World Malaria Day and the WHO …

Vaccines are the most cost-effective tools to control infectious diseases, yet the complexity of
malaria has frustrated all attempts to develop an effective product. This review concentrates …

A safe and effective malaria vaccine would contribute greatly to the control and prevention of
the disease. Although a review of global activity in malaria vaccine development does reflect …

Recent clinical trials inform the future for malaria vaccines | Communications Medicine Skip to
main content Thank you for visiting nature.com. You are using a browser version with limited …

Malaria vaccine development entered a new era in 2015 when the pre-erythrocytic
Plasmodium falciparum candidate RTS, S was favorably reviewed by the European …

The development of an effective malaria vaccine has taken many decades, but there is now
a good chance that the first malaria vaccine will be licensed within the next few years …